Asthma treatment

http://www.healasthma.com – XOPENEX HFA(TM) Metered-Dose Inhaler Now Available by Prescription for Patients with Asthma and Chronic Obstructive Pulmonary Disease (COPD) Symptoms XOPENEX HFA metered-dose inhaler now available (Photo ) Sepracor Inc. David P. Southwell Chief Financial Officer or Jonae R. Barnes Vice President Investor Relations – - Sepracor Inc. (Nasdaq SEPR) today announced that XOPENEX HFA(TM) (levalbuterol tartrate) Inhalation Aerosol, a hydrofluoroalkane (HFA) metered-dose inhaler (MDI), is now available by prescription in pharmacies nationwide. XOPENEX HFA is a short-acting beta-agonist indicated for the treatment or prevention of bronchospasm in patients years of age and older with… . Orlando Sentinel, The DRUG INHALERS USING CFCS TO BE BANNED AT END OF WASHINGTON — Inhalers using chlorofluorocarbons to dispense the drug albuterol will be banned at the end of the Food and Drug Administration said last week. Chlorofluorocarbons, once widely used as aerosol propellants in a variety of products, have been removed from use because they can damage the Earth’s protective ozone layer. Their use with albuterol, which helps prevent wheezing, shortness of breath and troubled breathing caused by asthma, chronic bronchitis and… . FD (FAIR DISCLOSURE) WIRE – Q Ivax Earnings Conference Call – Final OPERATOR Ladies and gentlemen, thank you for standing by. Welcome to the IVAX Corporation fourth-quarter year-end earnings conference call. For this conference, all the participant lines will be in a listen-only node. (Operator Instructions). As a reminder, today’s call is being recorded. I would now like to turn the conference over to Dr. Phillip Frost. Please go ahead, sir.PHILLIP FROST, CHAIRMAN, CEO, IVAX CORPORATION Good morning. I’d like to… . New York Times, The Market Place Copley Pharmaceutical reports some good news for investors. COPLEY PHARMACEUTICAL Inc., the embattled generic drug maker in the midst of a major recall and threatened by lawsuits, was able to report some good news on Friday. But investors will still have to wait for the other shoe to drop.Copley said the Food and Drug Administration had approved its versions of two widely used drugs that had recently lost patent protection naproxen sodium tablets for arthritis pain, originated by Syntex, and Lopressor for high blood pressure and angina, a… Fast-acting inhalers will cost more Asthma sufferers who rely on fast-acting “rescue inhalers” soon be scrambling to find the gadgets that help quell their sudden, agonizing attacks.The inhalers, which propel medicine into users’ airways, are in short supply at some hospitals and pharmacies across the country. And their availability is expected to worsen, as drug makers make a switch from the traditional devices to inhalers that are more environmentally friendly.The shortage… . The High Cost of Asthma Relief Shift to Environmentally Friendly Inhalers Cause Temporary Shortage Asthma sufferers who rely on fast-acting “rescue inhalers” soon be scrambling to find the gadgets that help quell their sudden, agonizing attacks. The inhalers, which propel medicine into users’ airways, are in short supply at some hospitals and pharmacies across the country. And their availability is expected to worsen, as drugmakers make a switch from the traditional devices to inhalers that are more environmentally friendly.The shortage… . FDA seeking input on asthma inhalers The government is asking asthma patients and doctors for help in deciding if it is time to gradually pull off the market certain asthma inhalers that pollute the environment. Older asthma inhalers use CFCs, the chlorofluorocarbons that deplete the ozone layer. An international treaty requires that they be phased out once suitable alternatives are available. Two CFC-free inhalers containing the popular asthma medicine albuterol, a bronchodilator, are on the market. The… . Daily Cougar, The (University of Houston) EDITORIAL FDA stab at ozone-damaging inhaler is unwarranted ( ) HOUSTON — As celebrities and musicians travel the world raising awareness of the carbon footprints everyone is making on this planet and how much damage we are causing to Mother Earth, the Federal Drug Administration has made its dent in the fight against global warming and helping reduce the hole in the ozone layer. The battle over global warming has entered a new arena health care.The FDA will phase out albuterol, a common drug for asthma patients that relaxes their… . New York Times, The Shift to Ozone-Friendly Inhaler Is Leading to Shortages and Rising Prices An environmental effort to protect the earth’s ozone layer could mean disruptions for the nation’s millions of asthma patients. A federally mandated shift to a more ozone-friendly version of the hand-held inhalers used to quell asthma attacks is creating spot shortages of the devices, because production of the older versions has declined even before producers of the new inhalers ramp up fully. The shift is also giving a few drug makers the rare chance to… Clinics Offer Free Asthma Inhalers To Comply With Federal Laws Beginning in , more than community health center and clinics across the state of Massachusetts, including Outer Cape Health Services in Wellfleet, began offering asthma inhalers free of charge to their uninsured and underserved asthma patients. The program, called the ASPIRE Campaign, comes at an important time. As of Dec. , all asthma patients in the United Sates who use albuterol CFC inhalers must switch to an environmentally friendly albuterol inhaler in compliance… –